Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hypoglycemia

• Study of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)
• Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects
• Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 Analogue
• A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
• Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose Excursions
• Oral Glibenclamide in Premature Hyperglycaemia (GALOP)
• Effect of Mizagliflozin on Postprandial Glucose and Insulin in Post-Bariatric Hypoglycemia Subjects
• ENSO 16 - Study in Healthy Subjects
• Canakinumab for the Treatment of Postprandial Hypoglycemia
• Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes
• A Research Study to Investigate the Safety and Effect of Dasiglucagon as a Hypoglycemia Rescue Therapy and How it Works in the Body of Children Under 6 Years of Age With Type 1 Diabetes
• Difference of Basal Insulin Titration Method in Reducing HbA1c Among Type 2 Diabetes Mellitus (T2DM) Patients.
• Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes
• Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes
• Metabolic Adaptation to High-frequent Hypoglycaemia in Type 1 Diabetes
• Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 Diabetes
• Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypass
• Empagliflozin for the Treatment of Postprandial Hypoglycemia
• Effect of ZT-01 on Glucagon During Hypoglycemia in Type 1 Diabetes Mellitus
• Effect of Sweetness Intensity of a Sucrose Solution on Blood Glucose Regulation and Energy Intake
• Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia
• Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes
• Late Preterm Corticosteroids and Neonatal Hypoglycemia
• Treatment of Post-bariatric Hypoglycaemia
• Efficacy and Safety of Dasiglucagon for Treatment of Post-bariatric Hypoglycemia in Roux-en-Y Gastric Bypass (RYGB) Operated Adults
• Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes
• Canagliflozin in Postprandial Hyperinsulinemic Hypoglycemia (CANA-PHH-RYGB)
• A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 Diabetes
• EFFECTS OF MOXIFLOXACIN AND GEMIFLOXACIN ON BLOOD GLUCOSE LEVEL OF EUGLYCEMICS:A PRE-CLINICAL AND CLINICAL STUDY
• Intermediate and Long Acting Insulin Young Children Type 1 Diabetes.
• Avexitide Safety and Efficacy to Treat Acquired Hyperinsulinemic Hypoglycemia
• Effect of Ciprofloxacin Versus Levofloxacin on QTc-interval and Dysglycemia
• Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes
• Study of the Pharmacologic Action of a GPR119 Agonist on Glucagon Counter-regulation During Insulin-induced Hypoglycemia in Type 1 Diabetes Mellitus
• Micro Glucagon During Exercise in Type 1 Diabetes
• Dual-hormone Closed-loop Glucose Control in Type 1 Diabetes
• A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus
• IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase
• Insulin Tolerance Test Study in Patients With Type 1 Diabetes
• Dasiglucagon in the Treatment of Postprandial Hypoglycaemia After Roux-en-Y Gastric Bypass
• Mini-Dose Glucagon to Treat Fasting-induced Hypoglycemia During Ramadan
• Restoration of Hypoglycemia Awareness With Metoclopramide
• A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients With T1DM
• The Physiological Effects of Human Ether-a-go-go-Related Gene (hERG)Blockade on Metabolism
• Glucagon Ready-to-Use for the Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D
• Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric Surgery
• G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes
• Mechanisms for Restoration of Hypoglycemia Awareness
• Evaluation of the Safety, Tolerability and Bioavailability of Dasiglucagon Following Subcutaneous (SC) Compared to IV Administration
• The Role of Glucose-Dependent Insulinotropic Polypeptide in the Pathological Glucose Homeostasis Of Type 1 Diabetes
• The Effect Lactate Administration on Cerebral Blood Flow During Hypoglycemia
• Effects of Dapagliflozin+Saxagliptin in Addition to Metformin v/s Saxagliptin or Dapagliflozin in Patients With DM2.
• Dapagliflozin Effects on Hypoglycemia
• Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM
• Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children
• Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)
• Collection of Breath and Sweat to Identify Indicators of Hypoglycemia
• Amitriptyline in Treating Hypoglycemia
• Glucose-dependent Insulinotropic Polypeptide as a Safeguard Against Hypoglycemia in Patients With Type 1 Diabetes
• Effect of Dapagliflozin on IAH in T1DM
• Carvedilol in Treating Hypoglycemia Unawareness
• Dapagliflozin During Exercise for the PrevenTion of Hypoglycaemia
• Pasireotide in the Treatment of Hypoglycemia Following Gastric Bypass Surgery
• Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses
• G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes
• Hypoglycemia and Autonomic Nervous System Function-B
• Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients
• A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects
• Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
• Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes Patients
• Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes
• Insulin-based Strategies to Prevent Hypoglycemia During Exercise
• A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus
• Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia
• Liver Glycogen and Hypoglycemia in Humans
• Improving Post-Prandial Blood Glucose Control With Afrezza During Closed-Loop Therapy
• Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise
• A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
• Postprandial Hypoglycemia in Patients After Bariatric Surgery With Empagliflozin and Anakinra - The Hypo-BEAR-Study
• Propranolol in Treating Hypoglycemia Unawareness
• Naloxone, Hypoglycemia and Exercise
• Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic Hypoglycemia
• A Study to Identify Biomarkers of Hypoglycaemia in Patients With Type 2 Diabetes
• Adrenergic System in Islet Transplantation
• Pasireotide in Hyperinsulinemic Hypoglycemia
• SugarFACT - Sugar Requirements For African Children Trial
• CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
• Identifying the Brain Substrates of Hypoglycemia Unawareness in Type 1 Diabetes
• Metabolic Consequences of Gastrointestinal Surgery
• Compassionate Use of SOM230 for Hyperinsulinemic/Hypoglycemia
• The Effects of Bariatric Surgeries on Glucose Metabolism
• An Open-Label Study of XOMA 358 in Patients With Hypoglycemia After Gastric Bypass Surgery
• Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia
• Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes
• CREON for the Treatment of Post-RYGB Hypoglycemia
• Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients
• Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia
• Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia
• The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes
• Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon
• Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics
• Glucose Control During Labour in Gestational Diabetes Mellitus With Insulin Treatment: A Randomized Controlled Trial
• Diabetes Islet Preservation Immune Treatment
• Role of GLP-1 in Hyperinsulinemic Hypoglycemia Post-bariatric Surgery
• Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia
• Treatment of Hypoglycemia Following Gastric Bypass Surgery
• How to be Safe With Alcoholic Drinks in Diabetes
• Brain Ketone Metabolism in Type 1 Diabetes
• Safety and Efficacy of ZP-Glucagon to Injectable Glucagon for Hypoglycemia
• G-Pen™ for Hypoglycemia Rescue in T1D Patients
• Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia
• Pharmacokinetics and Pharmacodynamics of BIOD-961 vs. Marketed Glucagons
• Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents
• Multiple Ascending Doses of ZP4207 Administered to HV to Evaluate the Safety, Tolerability, PKs and PDs of ZP4207
• Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes
• Single Ascending Doses of ZP4207 Administered in HV and in T1D to Evaluate Safety, Tolerability PKs and PDs of ZP4207 Compared to a Comparator
• A Randomized Double Blinded Study to Examine the Use of N-acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes
• The Effects of Hypoglycaemia in People With Type 2 Diabetes
• Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia
• Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting
• Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia
• Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes.
• Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories)
• Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes
• PK/PD Study With G-Pump (Glucagon Infusion) in T1DM Patients
• Study on Lixisenatide and Counterregulation to Hypoglycemia
• Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride
• Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults
• Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to Treat Severe Hypoglycemia
• Evaluate the Immunogenicity of a Novel Glucagon Formulation
• DPP4inhibitors in Type 1 Diabetes
• Intracellular Counter-regulatory Mechanisms Following Low Blood Glucose
• 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia
• Etiology, Assessment and Treatment of Post-gastric Bypass Severe Hypoglycemia
• GLP-1 and Hypoglycemia
• Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery
• Efficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 Diabetes
• Hypoglycemia and Autonomic Nervous System Function
• Dextrose Infusion by Burettes Versus Dextrose Boluses in Prevention of Neonatal Hypoglycemia
• Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus (DM)
• French Observational Survey to Assess Hypoglycaemia in Insulin-treated Diabetic Patients
• Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253)
• Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia
• The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes
• Use of Diazoxide in Acute Hypoglycaemia
• Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes
• Phase II Safety and Efficacy Study of 18FDOPA PET-CT in Children With Hyperinsulinemic Hypoglycemia
• Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia
• Hypoglycemia and the Mineralocorticoid Receptor
• Lactate to Treat Hypoglycemia
• Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1
• Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery
• Tight Glycaemic Control During Cardiac Surgery
• Vildagliptin and the Glucagon Response to Hypoglycemia in Insulin-Treated Patients With Type 2 Diabetes
• Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.
• Role of Glucagon-Like Peptide-1 in Postprandial Hypoglycemia
• Vildagliptin and the Glucagon Response to Hypoglycemia in Type 1 Diabetes
• Cognitive Function and Electrocardiogram (ECG) During Hypoglycemia and Blockade of the Renin-angiotensin System
• Naltrexone and Hypoglycemia in Type 1 Diabetes
• Investigating the Accuracy of the Home Glucose Monitors in Hypoglycemia
• Diazoxide In the Management Of Hypoglycemic Neonates
• Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes
• Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
• Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia
• The OBSTACLE Hypoglycemia Study (MK-0000-158)
• Intravenous Exenatide (Byetta) During Surgery
• Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes
• Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to Dysinsulinism
• To Evaluate the Response to Glucagon During Hypoglycemia
• Octreotide for the Treatment of Sulfonylurea-Associated Hypoglycemia
• The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients
• Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 4 Tesla. Substudy: Hypoglycemia Unawareness
• Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q4-Atomoxetine
• Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During Ramadan
• Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy Volunteers
• Risk of Hypoglycemia in Type 2 Diabetes
• Mechanisms of Hypoglycemia Associated Autonomic Failure
• Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism
• Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes
• Milk as Treatment for Hypoglycemia
• Bedtime Insulins and Oral Antihyperglycemic Drugs in Type 2 Diabetes
• Treatment With Erythropoietin and Cognition During Hypoglycaemia
• The Incidence of Hypoglycemia in Insulin Glargine-Treated Subjects With Diabetes Mellitus Upon Switching Between Bedtime and Morning Dosing
• Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q4
• Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia
• Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus
• Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus
• Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q5
• Hypoglycemia Associated Autonomic Failure in Type 1 DM
• Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q2
• Mechanisms of Hypoglycemia Associated Autonomic Dysfunction Question 2
• Isolated ACTH Deficiency in Patients With Hashimoto Thyroiditis
• Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM
• Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir
• Do Sulphonylureas Preserve Cortical Function During Hypoglycaemia?
• Comparison of Insulin Glargine and NPH Insulin at Night and at Hypoglycemia in Type 2 Diabetes
• Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus
• Islet Allotransplantation With Steroid Free Immunosuppression
• Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes
• Glucagon in the Treatment of Hypoglycemia in Newborn Infants of Diabetic Mothers
• The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia
• Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial)
• Prevention of Severe Hypoglycemia in Type 1 Diabetes
• Carnitine Levels and Carnitine Supplementation in Type I Diabetes
• Insulin Analogues and Severe Hypoglycaemia
• Adrenaline Injections to Children Born at Elective CS
• Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation
• hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients
• The Impact of Renin-angiotensin System on Brain Activation During Hypoglycaemia in Healthy Men, a PET Study